| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.36 | 3e-07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |